|
Market Closed -
BME
16:38:40 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 59.30 EUR | -0.42% |
|
-2.55% | -6.61% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 74.36 | +25.39% | 9 | ||||||
| 1,315.56 | +14.46% | 29 | ||||||
| 275.64 | +0.15% | 22 | ||||||
| 276.59 | +7.85% | 29 | ||||||
| 370.31 | +3.73% | 18 | ||||||
| 155.01 | -3.15% | 21 | ||||||
| 213 | +31.21% | 22 | ||||||
| 389.69 | -10.87% | 29 | ||||||
| 309.73 | +3.62% | 23 | ||||||
| 157.41 | +4.25% | 27 | ||||||
| 28.61 | +0.55% | 26 | ||||||
| 569.54 | +4.29% | 26 | ||||||
| 66.21 | -0.92% | 24 | ||||||
| 94.28 | +23.63% | 23 | ||||||
| 21.69 | +17.45% | 20 | ||||||
| 9,323.33 | +37.21% | 15 | ||||||
| 6,603.31 | +14.78% | 16 | ||||||
| 57.39 | +17.48% | 18 | ||||||
| 71.35 | +55.05% | 17 | ||||||
| 41.6 | +14.41% | 10 | ||||||
| Average | 1,020.73 | +13.03% | 21 | ||||||
| Weighted average by Cap. | 704.98 | +8.30% | 24 |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
